WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration on Friday approved Johnson & Johnson (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xarelto as a treatment to prevent strokes in patients with atrial fibrillation. Xarelto was already approved in the U.S. as a short-term ...
Related News:-
U S Food and Drug Administration Home Page
Home Page for the Food and Drug Administration (FDA)
J&J Mesh Approved by FDA Based on Recalled Device
By Alex Nussbaum and David Voreacos - Thu Oct 27 18:45:53 GMT 2011 (Corrects description of complications and number of surgeries cited by patient advocate in the ...
Drugs@FDA
A searchable catalog of FDA approved drug products both prescription and over the counter. The database includes information such as therapeutic equivalents and links to ...
Press Announcements
Sign up to receive FDA Press Releases. Note: Some links in press announcements are no longer active, but remain for archival purposes. For more information, contact the FDA's ...
J&J Mesh Approved by FDA Based on Recalled Device
(Corrects description of complications and number of surgeries cited by patient advocate in the 19th paragraph, and deletes incorrect quote in the 20th.) Oct. 20 ...
FDA approves Gilead-J&J HIV pill Complera
FOSTER CITY, Calif. (AP) -- The Food and Drug Administration has approved a once-per-day HIV treatment that combines Gilead Sciences Inc.'s drug Truvada with Johnson & Johnson ...
J&J Vaginal Mesh Approved by FDA Based on Older Recalled Device
Oct. 20 (Bloomberg) -- Johnson & Johnson, the world’s second-biggest health-care products maker, is battling lawsuits over a vaginal implant based on a similar ...
J&J's Xarelto Approved By FDA - Contract Pharma
DVT indication brings Lovenox-buster to U.S. market ... Johnson & Johnson subisidiary Janssen Pharmaceuticals has received FDA approval for Xarelto, a novel, once-daily, oral ...
FDA approves Gilead-J&J HIV pill Complera - Yahoo! News
Read 'FDA approves Gilead-J&J HIV pill Complera' on Yahoo! News. The Food and Drug Administration has approved a once-per-day HIV treatment that combines Gilead Sciences Inc.'s ...
No comments:
Post a Comment